For example, in pancreatic cancer, the upregulation of L1CAM in tumour-associated endothelial cells (TECs) enhanced IL-6 expression, activating the JAK/STAT3 signaling pathway, which in turn triggered EndMT associated with tumour progression and metastasis 86. Here, IL6 is linked to neoplasm.